World's First Malaria Vaccine Will Be Given to Thousands of Babies in Africa. Antibiotic resistance: 'Snot wars' study yields new class of drugs. Image copyright Thinkstock A new class of antibiotics has been discovered by analysing the bacterial warfare taking place up people's noses, scientists report.
Tests reported in the journal Nature found the resulting drug, lugdunin, could treat superbug infections. The researchers, at the University of Tubingen in Germany, say the human body is an untapped source of new drugs. The last new class of the drugs to reach patients was discovered in the 1980s. Nearly all antibiotics were discovered in soil bacteria, but the University of Tubingen research team turned to the human body. IBM Medical Anti virus breakthrough could enable new mode of vaccination against all viruses. As one of medicine’s largest challenges, viral infections often escape vaccines due to their natural ability to mutate rapidly and develop drug resistance easily.
Many viruses, such as Zika, Ebola and dengue fever, have grown into major global health epidemics with great human and economic toll. IBM Research and Singapore’s Institute of Bioengineering, Nanotechnology (IBN) announced they have identified a new breakthrough macromolecule that could help prevent deadly virus infections with a unique triple-play mechanism that can also help prevent viral drug resistance. The study exploits supramolecular chemistry – the study of large molecules designed with multiple features -- to help combat viral infection. HIV-Proof for 6 Months: New Treatment Provides Long-Term Protection. In Brief A team of researchers injected four human antibodies into monkeys, and a week after, proceeded to inject them with primate HIV.
The antibodies proved to be powerful enough to attack HIV, keeping the monkeys HIV-proof for 23 weeks. Antibodies, Not Vaccines The war against HIV and AIDS rages on, and we may have just taken another great step forward. New cancer drugs could treat lethal resistant prostate cancers. Men with aggressive prostate cancer that has stopped responding to conventional treatment could potentially benefit from a new class of cancer drug designed to overcome drug resistance, a new study suggests.
Researchers found that the drugs, called Hsp90 inhibitors, specifically target and inactivate a mechanism commonly used by prostate cancer cells to evade the effects of standard treatment. The findings provide vital information about the role of Hsp90 in drug-resistant prostate cancers, and open up potential new routes to cancer treatment based on blocking this or related proteins. In New Anti-Aging Strategy, Clearing Out Old Cells Increases Life Span of Mice by 25 Percent. Can removing old, tired-out cells extend an animal’s life span?
That’s is the conclusion of first-of-a-kind study by researchers at the Mayo Clinic, which found that mice lived about 25 percent longer on average if so-called “senescent” cells were cleared out from their bodies. The results, reported today in Nature, outline a possible new tactic for treating diseases including glaucoma, arthritis, and heart disease, and potentially extending human life, according to lead author Jan van Deursen, a molecular biologist at the Mayo Clinic in Rochester, Minnesota. Wheelchair-bound multiple sclerosis patients able to walk again after stem-cell therapy. A pioneering new stem cell treatment is reversing and then halting the potentially crippling effects of multiple sclerosis.
Multiple sclerosis (MS) is the most common chronic neurological disease which affects predominantly young people and interferes with their personal and professional lives. The greatest number of cases occurs between the ages of 30 and 40 years of age. Holly Drewry, 25, from Sheffield, who was wheelchair bound after the birth of her daughter Isla, now two. The treatment is being carried out at Royal Hallamshire Hospital in Sheffield and Kings College Hospital, London and involves use a high dose of chemotherapy to knock out the immune system before rebuilding it with stem cells taken from the patient’s own blood. * changes were seen within days of the stem cells * she walked out of the hospital Her treatment has now been reviewed and her condition found to have been dramatically halted. During the treatment, the patient's stem cells are harvested and stored. First New Antibiotic In 30 Years Could Prove Crucial In Fight Against Superbugs.
Extreme Regenerative Medicine. Tweet A recent infographic looking at radical life extension mentioned head/body transplants.
Medical Marijuana - What’s It Good For? Interest in medical marijuana is growing steadily, fanned by a large political movement that aims to increase its availability and legality.
Pine bark substance could be potent melanoma drug. HERSHEY.
Pa. -- A substance that comes from pine bark is a potential source for a new treatment of melanoma, according to Penn State College of Medicine researchers. Current melanoma drugs targeting single proteins can initially be effective, but resistance develops relatively quickly and the disease recurs. In those instances, resistance usually develops when the cancer cell's circuitry bypasses the protein that the drug acts on, or when the cell uses other pathways to avoid the point on which the drug acts. Resistance to last-resort antibiotic has now spread across globe. Aging May Be Halted By Taking This Common Sports Supplement.
Scientists in Switzerland have identified the genes responsible for aging and a longer lifespan, and may have uncovered possible therapies.
Anti-aging science is moving at breakneck speed. Just last week the FDA approved an anti-aging drug trial for 2016 for the diabetes drug Metformin. It signifies the first time that the FDA has recognized aging, rather than a specific disease, as a drug target. Scientists in Switzerland waded through 40,000 genes from three different organisms to identify the specific genes responsible for aging. 1,000-Year-Old Salve Recipe Kills MRSA Cultures.